Clinical Trial Update: Effect of Tredaptive on Serum Lipoproteins and Inflammatory Markers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effect of Tredaptive on serum lipoproteins and inflammatory markers in hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• TREDAPTIVE (niacin/laropiprant)

Snippet

Sponsor: Manchester University NHS Foundation Trust | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED